The authors investigate the safety of minimally invasive Transcatheter Aortic Valve Replacement (MA-TAVR) and its learning curve. MA-TAVR was performed by a team consisting of a cardiologist and cardiac surgeon. The patient was teated in a catheterization laboratory under conscious sedation.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter
August 16, 2015
August 14, 2015
This is an observational outcome study for the comparative effectiveness of SAVR–TAVR procedures for the treatment of severe aortic stenosis at 93 Italian centers.
August 3, 2015
In this manuscript the authors describe their findings in a retrospective review of prospectively obtained 5-year follow up data on 353 patients undergoing transcatheter aortic valve implantation (TAVI) with the CoreValve prosthesis in 8 Italian centres.Transfemoral access was used in 317 patients (89.8%); in the rest of the patients in whom the tran
July 27, 2015
Clinical trials evaluating transcatheter mitral valve interventions for severe mitral regurgitation (MR) are complex.
June 24, 2015
This clinical case describes the successful treatment of severe aortic stenosis in a patient whose aortic anatomy precluded the traditional TAo approach. A 10mm Dacron graft was anastomosed end-to-side to provide adequate distance between the aortic annulus and the sheath insertion site.
Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement
June 24, 2015
The authors of this study aimed to compare the quality of life (QoL) after Transapical transcatheter aortic valve implantation (TA-TAVR) versus surgical aortic valve replacement (SAVR).
June 19, 2015
The FDA approved Edwards' Sapien third generation transcatheter aortic valve, designed to limit paravalvular leakage by incorporating a skirt at the base of the valve. The approval was based on results of the PARTNER II S3 study, which demonstrated improved rates of paravalvular leakage at 30 days (<4%) compared to 10% to 20% rates for other valv
June 17, 2015
In this paper the authors report on the 2-year results of the randomized US pivotal trial for surgical and self-expanding percutaneous aortic prosthetic valves. The survival benefit observed at 1 year in the transcatheter group were sustained at two years.
June 14, 2015
In this manuscript the authors report on data from the German Aortic Valve Registry (GARY) comprising 15964 transcatheter aortic valve replacement (TAVR) procedures performed from 2011 to 2013 evaluating severe vital complications (SVCs), technical complications of the procedures (TCOs), other complications, conversion to sternotomy and in-hospital d
June 13, 2015
In this open-access article, the authors describe their findings in a systematic review of transcatheter heart valve (THV) failures, comprising 70 articles and 87 individual cases. Unusual complications such as late embolization (mostly into the left ventricle) and prosthetic compression (exclusively in balloon expandable THVs) are described.